SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2004 Commission File Number: 1-14862 Braskem S.A. -------------------------------------------------------------- (Exact Name as Specified in its Charter) N/A -------------------------------------------------------------- (Translation of registrant's name into English) Rua Eteno, 1561, Polo Petroquimico de Camacari Camacari, Bahia - CEP 42810-000 Brazil -------------------------------------------------------------- (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). --------------- Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7). --------------- Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- --------------------. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BRASKEM S.A. Date: March 19, 2004 By: /s/Mauricio Roberto de Carvalho Ferro --------------------------------------------- Name: Mauricio Roberto de Carvalho Ferro Title: Vice-President and General Counsel -2- EXHIBIT INDEX Exhibits Description of Exhibits -------- ----------------------- 99.1 Relevant Fact regarding Copene Monomeros Especiais S.A. Merger 99.2 Notice of Convocation (March 31 Meeting) 99.3 Copene Monomeros Especiais S.A. Valuation Report 99.4 Protocol and Justification of Copene Monomeros Especiais S.A. Merger -3-